Cargando…

Infectious etiology in multiple sclerosis: the debate continues

‘Demonstrating Infectious Cause: Viral and Bacterial Infections in MS and Related Disorders’ was held in Brighton, UK, 23–25 August 1999.

Detalles Bibliográficos
Autores principales:	González-Scarano, Francisco, Rima, Bert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 1999
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172582/ https://www.ncbi.nlm.nih.gov/pubmed/10644155 http://dx.doi.org/10.1016/S0966-842X(99)01634-0

Ejemplares similares

VIRAL ETIOLOGY OF MULTIPLE SCLEROSIS: A CRITIQUE OF THE EVIDENCE
por: Gonzalez-Scarano, F., et al.
Publicado: (1985)

Integrality of the therapeutic and pharmaceutical care: a necessary debate
por: Vieira, Fabiola Sulpino
Publicado: (2017)

Elusive data underlying debate at the prokaryote-eukaryote divide
por: Gerlitz, Marie, et al.
Publicado: (2018)

Female genital mutilation requires public health and political debate in Finland
por: Savela, Roosa-Maria, et al.
Publicado: (2023)

Comment on: “Gene–Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate”
por: Onur Cura, Duygu
Publicado: (2019)

A gene drive is a gene drive: the debate over lumping or splitting definitions
por: James, Stephanie L., et al.
Publicado: (2023)

Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
por: Korczyn, Amos D.
Publicado: (2013)

Debate over the importance and meaning of native range in invasion biology: reply to Courchamp et al.
por: Pereyra, Patricio Javier, et al.
Publicado: (2020)

Energy restriction in people with multiple sclerosis: Is time more important than calories?
por: Ghezzi, Laura
Publicado: (2022)

Dilated Virchow Robin spaces in multiple sclerosis – a generalised marker of disease?
por: Vivash, Lucy
Publicado: (2023)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

Understanding the etiology and epidemiology of meningitis and encephalitis: now and into the future
por: Redenbaugh, Vyanka, et al.
Publicado: (2022)

Diarrhea after autologous stem cell transplantation in low-middle income countries: is Clostridium difficile the most prevalent infectious etiology?()
por: Cunha, Renato
Publicado: (2018)

Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis
por: Ryan,, Melody, et al.
Publicado: (2009)

Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continues
por: Kayed, Rakez
Publicado: (2021)

Veterinary infectious diseases control in China
por: Zhang, Xiaodong
Publicado: (2019)

Asgard archaea do not close the debate about the universal tree of life topology
por: Da Cunha, Violette, et al.
Publicado: (2018)

Empowering African genomics for infectious disease control
por: Folarin, Onikepe A, et al.
Publicado: (2014)

Nuanced risk assessment for emerging infectious diseases
por: Fisman, David N, et al.
Publicado: (2014)

REACTing: the French response to infectious disease crises
por: Delfraissy, Jean-François, et al.
Publicado: (2016)

Infectious diseases in China in the post-SARS era
por: Gibney, Katherine B, et al.
Publicado: (2017)

Infectious diseases compensation in the USA: the relative value
por: El Helou, Guy, et al.
Publicado: (2022)

Relaxation of anti-COVID-19 measures reveals new challenges for infectious disease outbreak forecasting
por: Brady, Oliver J, et al.
Publicado: (2023)

Technology to advance infectious disease forecasting for outbreak management
por: George, Dylan B., et al.
Publicado: (2019)

Addressing the socioeconomic divide in computational modeling for infectious diseases
por: Tizzoni, Michele, et al.
Publicado: (2022)

Wastewater surveillance for rapid identification of infectious diseases in prisons
por: Hassard, Francis, et al.
Publicado: (2022)

Developing medical imaging AI for emerging infectious diseases
por: Huang, Shih-Cheng, et al.
Publicado: (2022)

Endovascular treatment for multiple sclerosis: The intersection of science, policy and the public
por: Laupacis, Andreas, et al.
Publicado: (2010)

The value of early transmission dynamic studies in emerging infectious diseases
por: McBryde, Emma
Publicado: (2020)

Climate change and infectious disease: time for a new normal?
por: Heffernan, Claire
Publicado: (2015)

The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018)

Public health surveillance of infectious diseases: beyond point mutations
por: Goodman, Laura B, et al.
Publicado: (2021)

COVID-19 through the Latinx infectious disease doctor's eyes
por: Gardner, Annelys Roque
Publicado: (2021)

The importance of molecular diagnostics for infectious diseases in low-resource settings
por: Okeke, Iruka N., et al.
Publicado: (2021)

The Role of Fungi in the Etiology of Multiple Sclerosis
por: Benito-León, Julián, et al.
Publicado: (2017)

Infection and the etiology and pathogenesis of multiple sclerosis
por: Steiner, Israel, et al.
Publicado: (2001)

COVID-19 will continue but the end of the pandemic is near
por: Murray, Christopher J L
Publicado: (2022)

Yeast apoptosis debate continues
por: LeBrasseur, Nicole
Publicado: (2004)

DSM-5: the debate continues
por: Buxbaum, Joseph D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fo7du6cam17gu45qqg61k3mspa